Director Epidemiology
Verantos
Director Epidemiology
Verantos
Real-world data curation for pharmacoepidemiology
Overview
Located in California’s Silicon Valley, Verantos is the global leader in high-validity real-world evidence at scale. By applying artificial intelligence to the complete patient record, Verantos enables life sciences organizations to generate high-validity evidence across therapeutic areas with measured accuracy, completeness, and traceability. Credible evidence accelerates clinical development, market access, medical affairs, pharmacovigilance, and regulatory initiatives.
Verantos believes that advanced RWE requires a group of dedicated and highly-trained professionals who are specialists in the field. Our team consists of physicians, data scientists, clinical researchers and engineers with a deep knowledge of, and extensive experience in, protocol development, health system engagement, electronic health record integration, de-identification, artificial intelligence, data enrichment, study implementation and validity assessment. In addition, we have vast experience within the healthcare ecosystem, including pharma, payer, provider, and regulatory.
Position Scope and Location
You will work on advanced RWD/RWE projects with innovative biopharma companies and health systems to advance clinical research by leveraging our technology and expertise. Priorities include customer-facing and writing capabilities.
Major Responsibilities
→ Develop content required for execution and publication on projects that make significant contributions to science
→ Engage with key internal and external stakeholders
→ Execute scientifically-advanced projects
Position Requirements and Experience
Required
Preferred
Personal and Professional Characteristics
Verantos provides high-quality real-world data for pharmacoepidemiology, enhanced by careful curation and clinical-inference processes, plus agentic AI tools to generate valid evidence quickly and at lower cost. Its product stack collects and harmonizes real-world data, applies domain-specific curation and inference, and uses AI-assisted workflows to produce evidence for clinical development, comparative effectiveness, regulatory submissions, label expansion, safety assessments, and post-marketing commitments. Unlike traditional HEOR approaches, Verantos emphasizes data quality, structured interpretation, and scalable AI-driven evidence generation to accelerate decision-making. The company's goal is to enable faster, more accurate evidence generation that supports drug development, regulatory approval, and long-term safety monitoring while reducing time and expense.
Explore more opportunities at Verantos